Vascular Flow Technologies Gets a $14.3 Million Shot in the Arm
Vascular Flow Technologies said today it raised $14.3 million (£10 million) through multiple rounds of financing to support research & development, strategic joint development and out-licensing agreements with industry partners.
The funding round consisted of 2 tranches; a $10 million (£7 million) loan note restructuring into Series A ordinary preference shares and a $4.3 million (£3 million) Series B financing round led by an undisclosed family office and joined by international and individual angel investors, the company said.
The U.K.-based company will use the funds as it shifts its focus towards operating as a technology transfer business, applying its Spiral Laminar Flow technology to vascular and endovascular devices.
The funding round consisted of 2 tranches; a $10 million (£7 million) loan note restructuring into Series A ordinary preference shares and a $4.3 million (£3 million) Series B financing round led by an undisclosed family office and joined by international and individual angel investors, the company said.
The U.K.-based company will use the funds as it shifts its focus towards operating as a technology transfer business, applying its Spiral Laminar Flow technology to vascular and endovascular devices.